2Pamphlion DH, Farrell DH, Donaldson C, et al. Development of lymphocytoxin and platelet rective antibodies: a prospective study in patients with acute leukemia[J]. Vox Sang, 1989,57:177-180. 被引量：1
3Godeau B, Fromont P, Seror T, et al. Platelet alloim munization after multiple transfusions:A prospective study of 50 patients [J]. Br J Haematol, 1992,81:395-400. 被引量：1
4Kekomaki S, Volin L, koistinen P, et al. Successful treatment of platelet transfusion refractoriness: the use of platelet matched for both human leucyte antigens (HLA) and human platelet alloantigens (HPA) in alloimmunized patients with leukacmia[J]. Eur J Heamatol, 1998,60:112-118. 被引量：1
5Novotny VMJ. Prevention and management of platelet transfusion refractoriness[J]. Vox Sang, 1999,76:1-13. 被引量：1
6[2]Ho99e DE, Dutcer JP, Aisener J, et al. lymphocytoxic antibody is a predictor of response to random donor platelet transfusion. Am J Hematol, 1983, 14:363～369 被引量：1
